CHLORHEXIDINE GLUCONATE 0.12% ORAL RINSE, USP MOUTHWASH

Země: Kanada

Jazyk: angličtina

Zdroj: Health Canada

Aktivní složka:

CHLORHEXIDINE GLUCONATE

Dostupné s:

SAGE PRODUCTS LLC

ATC kód:

A01AB03

INN (Mezinárodní Name):

CHLORHEXIDINE

Dávkování:

0.12%

Léková forma:

MOUTHWASH

Složení:

CHLORHEXIDINE GLUCONATE 0.12%

Podání:

BUCCAL

Jednotky v balení:

15ML/473ML

Druh předpisu:

Prescription

Terapeutické oblasti:

MISCELLANEOUS ANTI-INFECTIVES

Přehled produktů:

Active ingredient group (AIG) number: 0107629007; AHFS:

Stav Autorizace:

CANCELLED POST MARKET

Datum autorizace:

2022-04-22

Charakteristika produktu

_ _
_ _
_Page 1 of 19_
PRODUCT MONOGRAPH
CHLORHEXIDINE GLUCONATE 0.12% ORAL RINSE, USP
Chlorhexidine Gluconate 0.12% Oral Rinse
Liquid, 0.12% Chlorhexidine Gluconate
Antigingivital Oral Rinse
Sage Product LLC
3909 Three Oaks Road
Cary, IL 60013
USA
Date of Preparation:
February 17, 2015
Submission Control No: 180308
_ _
_ _
_Page 2 of 19_
TABLE OF CONTENTS
PART I: HEALTH PROFESSIONAL INFORMATION
.........................................................3
SUMMARY PRODUCT INFORMATION
........................................................................3
INDICATIONS AND CLINICAL USE
..............................................................................3
CONTRAINDICATIONS
...................................................................................................3
WARNINGS AND PRECAUTIONS
..................................................................................4
ADVERSE REACTIONS
....................................................................................................6
DOSAGE AND ADMINISTRATION
................................................................................6
OVERDOSAGE
..................................................................................................................7
ACTION AND CLINICAL PHARMACOLOGY
..............................................................8
STORAGE AND STABILITY
............................................................................................9
SPECIAL HANDLING INSTRUCTIONS
.........................................................................9
DOSAGE FORMS, COMPOSITION AND PACKAGING
.............................................10
PART II: SCIENTIFIC INFORMATION
...............................................................................11
PHARMACEUTICAL INFORMATION
..........................................................................11
CLINICAL TRIALS
..........................................................................................................12
DETAILED PHARMACOLOGY
.........................